It consisted of 18 women participating in a 5-day dry immersion test to assess the risk of developing potentially life-threatening blood clots. The results support existing evidence that women are at ...

Biogen’s successor to Spinraza (nusinersen) has shown benefit in spinal muscular atrophy (SMA) patients who had suboptimal clinical status despite prior administration of gene therapy. In the Phase Ib ...

Barclays 28th Annual Global Healthcare Conference March 12, 2026 8:30 AM EDTCompany ParticipantsDavid Hallal - ...

When winter sets in and food becomes scarce, some mammals hibernate, entering a state of deep rest that slashes their energy needs and allows them to fast for months. However, fasting deprives them of ...

Mutations that cause spinal muscular atrophy (SMA) may lead to abnormalities in the development of cells in the spinal cord, a study found.

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies ...

The latest figures from the Department for Work and Pensions show over 3.9 million people across England and Wales are now receiving Personal Independence Payment (PIP), worth up to £749 a month for ...

Epirium Bio Inc. (Epirium), a clinical-stage biopharmaceutical company advancing medicines for neuromuscular and fibrotic diseases, announced today that new clinical and translational data for MF-300 ...

Isro and the All India Institute of Medical Sciences (AIIMS) have signed an MoU to collaborate on space medicine research aimed at supporti.

SMA newborn screening may help infants start treatment sooner, which researchers say could support better motor development outcomes.